Hematology
Consultant – Clinical Haematology7+ years
Fortis Hospitals
Mumbai
Dr. Hamza Dalal is a Consultant Clinical Haematologist, Haemato-Oncologist and Bone Marrow Transplant Physician associated with Fortis Healthcare in Mumbai. He specialises in the diagnosis and treatment of blood disorders, blood cancers and conditions requiring stem cell transplantation. His clinical interests include both benign and malignant haematological diseases in adults and selected paediatric patients.
Dr. Hamza Dalal completed his MBBS from Lokmanya Tilak Municipal Medical College, Sion, Mumbai, followed by an MD in General Medicine from B. J. Government Medical College, Pune. He subsequently completed a DNB in Clinical Haematology at Mazumdar Shaw Cancer Centre, Narayana Health City, Bengaluru. He has also completed postgraduate education in geriatric medicine.
His professional qualifications include gold medals in MD General Medicine and DNB Clinical Haematology. His official website identifies him as a recipient of a National Gold Medal awarded at the 22nd National Board of Examinations convocation in 2022. His professional background includes specialist training at centres managing complex blood cancers and bone marrow transplantation.
Dr. Dalal's principal areas of expertise include leukaemia, lymphoma, multiple myeloma, anaemia, thrombocytopenia, thalassaemia, aplastic anaemia and clotting disorders. Treatment may involve diagnostic investigations, medication, chemotherapy, blood product support or specialised interventions according to the disease type and severity.
He has extensive clinical exposure to bone marrow and haematopoietic stem cell transplantation. Fortis reports that he assisted in more than 700 bone marrow transplant procedures and independently conducted more than 50. His supplementary professional references also document involvement in transplant preparation, donor and recipient care, and the management of complications associated with blood disorders.
In addition to clinical work, Dr. Hamza Dalal participates in haematology research, academic conferences and professional education. His official website lists publications, scientific presentations and memberships in national and international haematology organisations. Patients seeking specialist consultation for blood cancers, unexplained blood count abnormalities or bone marrow transplantation in Mumbai may consult him for diagnosis, treatment planning and ongoing haematological care.
Anaemia occurs when haemoglobin levels are reduced, limiting the blood's ability to carry oxygen effectively. Causes may include iron deficiency, vitamin deficiency, chronic disease or bone marrow disorders. Treatment depends on identifying the underlying cause and may involve supplements, medication or other specialist interventions.
Thrombocytopenia refers to a reduced platelet count that may increase bleeding risk. Causes include immune disorders, infections, medications and bone marrow diseases. Assessment involves blood tests and clinical examination. Treatment depends on the cause, platelet count and whether significant bleeding is present.
Leukaemia is a cancer affecting blood-forming cells, usually involving the bone marrow and blood. Treatment depends on the type, molecular characteristics and disease severity. Options may include chemotherapy, targeted therapy, immunotherapy or stem cell transplantation for selected patients.
Lymphoma is a cancer of lymphocytes and includes Hodgkin and non-Hodgkin lymphoma. Diagnosis often requires tissue biopsy and additional testing. Treatment is based on lymphoma subtype and stage and may involve chemotherapy, immunotherapy, targeted medications, radiotherapy or stem cell transplantation in selected cases.
Multiple myeloma is a blood cancer involving plasma cells in the bone marrow. It may affect bones, kidneys and blood counts. Management can involve combinations of targeted medicines, immunomodulatory treatment, corticosteroids and autologous stem cell transplantation for eligible patients.
Aplastic anaemia occurs when the bone marrow produces insufficient blood cells. Patients may develop fatigue, infection or bleeding symptoms. Treatment depends on disease severity and may involve supportive care, immunosuppressive therapy or haematopoietic stem cell transplantation for selected patients.
Thalassaemia is an inherited blood disorder affecting haemoglobin production. More severe forms may require regular blood transfusions and management of iron overload. Some patients may be candidates for curative treatments such as stem cell transplantation following specialist evaluation.
Haemophilia is an inherited bleeding disorder caused by deficiency of certain clotting factors. Management may involve clotting factor replacement, preventive treatment and specialist care during bleeding episodes or surgery. Treatment is tailored to disease severity and available therapies.
Bone marrow aspiration and biopsy obtain samples from the marrow for laboratory examination. These procedures may help diagnose leukaemia, lymphoma, multiple myeloma, unexplained low blood counts and other disorders. The samples are evaluated through microscopy and additional specialised testing when necessary.
Autologous stem cell transplantation uses a patient's own collected stem cells after intensive treatment. It may be considered for selected patients with multiple myeloma or lymphoma. The procedure requires specialist assessment, infection prevention, supportive care and ongoing monitoring after transplantation.
Allogeneic stem cell transplantation uses blood-forming stem cells from a compatible donor. It may be considered for certain blood cancers and bone marrow disorders. Treatment requires donor matching, conditioning therapy and monitoring for complications including infection and graft-versus-host disease.
Chemotherapy uses medicines to destroy malignant cells or prevent their growth. It is used in several forms of leukaemia, lymphoma and other blood cancers. Drug selection and treatment schedules depend on the diagnosis, disease characteristics and patient health, with close monitoring for side effects.
Blood transfusions may be needed to manage severe anaemia, low platelet counts or complications of haematological disease and treatment. Decisions are based on symptoms, blood test results and clinical circumstances. Appropriate blood product selection and monitoring are important for transfusion safety.
Haematological emergencies include severe bleeding, profound anaemia, dangerous blood count abnormalities and complications of blood cancers. These conditions may require urgent hospital assessment, transfusion support, medication or intensive treatment. Rapid identification and coordinated specialist care are important for preventing serious complications.
MBBS, MD (General Medicine), PGDGM (Postgraduate Diploma in Geriatric Medicine), DNB (Clinical Haematology)
Anaemia Evaluation and Treatment, Thrombocytopenia Management, Leukaemia Treatment, Lymphoma Treatment, Multiple Myeloma Management, Aplastic Anaemia Treatment, Thalassaemia Management, Haemophilia Care, Bleeding and Clotting Disorders, Bone Marrow Aspiration, Bone Marrow Biopsy, Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Chemotherapy for Blood Cancers, Blood Transfusion Support, Haematological Emergency Management, Adult and Paediatric Haematology, Peri-Transplant Care.
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Hamza Dalal
Dr. Hamza Dalal is a Clinical Haematologist, Haemato-Oncologist and Bone Marrow Transplant Physician associated with Fortis Healthcare in Mumbai.
He holds MBBS, MD General Medicine, PGDGM and DNB Clinical Haematology.
Fortis Kalyan reports five years of haematology/BMT experience and eight years in clinical medicine. A separate Fortis profile and Satyug Healthcare report approximately seven years.
Yes. His documented expertise includes leukaemia, lymphoma and multiple myeloma.
Fortis reports that he has assisted in more than 700 transplants and independently conducted more than 50.
Contact us for personalized help or to schedule an appointment.